Near-InfraRed Spectroscopy of Auricular Stimulation
Launched by UNIVERSITY OF PITTSBURGH · Feb 7, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how auricular stimulation, which means gently touching the ears, affects brain activity in healthy adults. Researchers will use special sensors that measure brain activity with infrared light, while participants wear a cap with these sensors attached. The study is designed to be non-invasive, meaning it won't involve any surgery or needles, and each participant will only need to visit the study site once.
To be eligible for this study, participants must be at least 18 years old and in good health. However, people who have chronic pain, certain skin conditions on their ears, or a history of substance misuse will not be able to participate. If you are interested in this study, you can expect a friendly environment where your brain activity will be monitored as they explore how stimulating the ears may impact brain function. This research could provide valuable insights into how our bodies interact with sensory stimulation.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age of at least 18 years
- Exclusion Criteria:
- • 1. frequent or chronic pain requiring the use of pain-relieving medications more than twice per week, on average, in the last 3 months,
- • 2. history or symptoms of neuropathy,
- • 3. active lesions or skin disruptions to either ear,
- • 4. recent (\< 3 mo) illicit drug use,
- • 5. history of substance misuse/abuse,
- • 6. current or recent (\<1 month) opioid or marijuana use, and
- • 7. current regular use of psychoactive prescription medications
About University Of Pittsburgh
The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pittsburgh, Pennsylvania, United States
Patients applied
Trial Officials
Keith Vogt, MD, PhD
Principal Investigator
University of Pittsburgh
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported